R N Amaria
Overview
Explore the profile of R N Amaria including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
2307
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tetzlaff M, Adhikari C, Lo S, Rawson R, Amaria R, Menzies A, et al.
Ann Oncol
. 2020 Aug;
31(11):1569-1579.
PMID: 32739408
Background: Recent clinical trials demonstrated the safety and efficacy of neoadjuvant dabrafenib and trametinib (DT) among patients with surgically resectable clinical stage III BRAFV600E/K mutant melanoma. Although patients achieving a...
2.
Tetzlaff M, Messina J, Stein J, Xu X, Amaria R, Blank C, et al.
Ann Oncol
. 2018 Jun;
29(8):1861-1868.
PMID: 29945191
Background: Clinical trials have recently evaluated safety and efficacy of neoadjuvant therapy among patients with surgically resectable regional melanoma metastases. To capture informative prognostic data connected to pathological response in...
3.
Liu L, Toung J, Jassowicz A, Vijayaraghavan R, Kang H, Zhang R, et al.
Ann Oncol
. 2018 Apr;
29(6):1445-1453.
PMID: 29635542
Background: Targeted methylation sequencing of plasma cell-free DNA (cfDNA) has a potential to expand liquid biopsies to patients with tumors without detectable oncogenic alterations, which can be potentially useful in...
4.
Gopalakrishnan V, Spencer C, Nezi L, Reuben A, Andrews M, Karpinets T, et al.
Science
. 2017 Nov;
359(6371):97-103.
PMID: 29097493
Preclinical mouse models suggest that the gut microbiome modulates tumor response to checkpoint blockade immunotherapy; however, this has not been well-characterized in human cancer patients. Here we examined the oral...
5.
Amaria R, Bowles D, Lewis K, Jimeno A
Drugs Today (Barc)
. 2012 Jul;
48(7):459-67.
PMID: 22844657
Vismodegib is a novel, small-molecule inhibitor of smoothened, a key component of the hedgehog signaling pathway. Increased hedgehog pathway signaling is critical in the development of hereditary and spontaneous basal...
6.
Amaria R, Lewis K, Jimeno A
Drugs Today (Barc)
. 2012 Mar;
48(2):109-18.
PMID: 22384451
Advanced melanoma has a poor prognosis due to its resistance to traditional chemotherapeutics, leading to the search for alternative treatment approaches. With the finding that approximately 50% of melanomas harbor...